Hiesinger Kerstin, Schott Annika, Kramer Jan S, Blöcher René, Witt Finja, Wittmann Sandra K, Steinhilber Dieter, Pogoryelov Denys, Gerstmeier Jana, Werz Oliver, Proschak Ewgenij
Institute of Pharmaceutical Chemistry, Goethe University Frankfurt, Max-von-Laue-Strasse 9, 60438 Frankfurt, Germany.
Department of Pharmaceutical/Medicinal Chemistry, Institute of Pharmacy, Friedrich-Schiller-University Jena, Philosophenweg 14, 07743 Jena, Germany.
ACS Med Chem Lett. 2019 Oct 30;11(3):298-302. doi: 10.1021/acsmedchemlett.9b00330. eCollection 2020 Mar 12.
Multitarget anti-inflammatory drugs interfering with the arachidonic acid cascade exhibit superior efficacy. In this study, a prototype dual inhibitor of soluble epoxide hydrolase (sEH) and LTA hydrolase (LTAH) with submicromolar activity toward both targets has been designed and synthesized. Preliminary structure-activity relationship studies were performed to identify optimal substitution patterns. X-ray structure analysis of a promising dual inhibitor in complex with sEH, as well as molecular docking with LTAH provided a rationale for further optimization. Hereby, scaffold extension was successfully applied to yield potent dual sEH/LTAH inhibitors. The spectrum of pro- and anti-inflammatory lipid mediators was evaluated in M1 and M2 macrophages, stimulated with LPS, and incubated with the most promising compound . The effect of on the inflammatory lipid mediator profile characterizes dual sEH/LTAH inhibitors as an interesting option for future anti-inflammatory agent investigations.
干扰花生四烯酸级联反应的多靶点抗炎药物具有卓越的疗效。在本研究中,设计并合成了一种对可溶性环氧化物水解酶(sEH)和LTA水解酶(LTAH)均具有亚微摩尔活性的双靶点抑制剂原型。开展了初步的构效关系研究以确定最佳取代模式。对一种有前景的双靶点抑制剂与sEH的复合物进行X射线结构分析,并与LTAH进行分子对接,为进一步优化提供了理论依据。据此,成功应用骨架扩展法得到了强效的sEH/LTAH双靶点抑制剂。在用脂多糖刺激并与最有前景的化合物孵育的M1和M2巨噬细胞中评估了促炎和抗炎脂质介质的谱。该化合物对炎症脂质介质谱的影响表明,sEH/LTAH双靶点抑制剂是未来抗炎药物研究的一个有趣选择。